CClinicalTrials.gg
CompletedNCT03746548Updated Jan 2, 2020

Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini

An interventional study of Adhear and Contact Mini (CM) in Conductive Hearing Loss, sponsored by Dominik Riss. Completed at 1 site in Austria. Open to participants aged 13 Years to 99 Years. Per ClinicalTrials.gov, last updated 2020-01-02.

Sponsored by Dominik Riss · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jan 2018, registered Nov 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Randomized
Ages
13 Years to 99 Years
Sex
All
01

Study summary

Patients with conductive hearing loss fitting the inclusion criteria will be asked to participate in the study. All subjects will be randomized to wear either first the adhesive or the conventional bone conduction hearing aid. They will wear either device for two weeks. They will use the second device for another two weeks. Audiologic tests and quality of life questionnaires will be assessed at the beginning of the study after two weeks with the first device and after two weeks with the second device. Additionally, all patients will be asked to keep a diary including daily wearing time of the device.

Read the detailed description

The primary objective of this study is to show, that the ADHEAR will be worn \~75%(\~11 to 15 hours per day) of the waking hours, whereas the Contact Mini will be worn \~ 50% (\~5 - 8 hours per day) of the waking hours (p\<0.05). The authors expect this difference due to increased wearing comfort, reduced/no pressure to the skin of the ADHEAR. The primary objective will be assessed with the diary patients are asked to use.

Audiologic testing will consist of free field audiometry, Freiburger monosyllables test and Oldenburg sentence test. All tests will be performed with and without the devices.

Quality of life and hearing related questionnaires will consist of the AQoL-8D and the SSQ12.

02

Conditions studied

  • Conductive Hearing Loss
03

In context

Hearing Loss

1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.

This study's enrollment of 13 is below the median of 40 across 764 interventional studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

Dominik Riss is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion criteria

    • Unilateral and/or bilateral conductive hearing loss (CHL)
    • The bone conduction threshold for the patient's affected ear shall be better than or equal to 25 dB HL (PTA BC for 0.5, 1, 2, 3 kHz).
    • Subjects aged 13 years or older
    • Capable of the German language
    • Willingness and ability to perform all tests required for the study
    • Signed, and dated informed consent before the start of any study specific procedure

Exclusion Criteria:

Exclusion criteria

  • Pregnancy or breastfeeding
  • Patient is intolerant of the materials as described by Manufacturer's IFU
  • Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter.
  • Patient cannot perform the audiological tests or is unable to fill out the questionnaires.
  • Patient presents with retrocochlear, or central auditory disorder.
  • any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Other
    CM-ADHEAR

    First patients use the Contact Mini (conventional bone conduction device used with a soft band or headband) then ADHEAR (adhesive bone conduction device)

    Device: Adhear · Device: Contact Mini (CM)

  • Other
    ADHEAR - CM

    First patients use ADHEAR (adhesive bone conduction device) then CM (conventional bone conduction device used with a soft band or headband)

    Device: Adhear · Device: Contact Mini (CM)

Interventions

  • DeviceAdhear

    Patients are wearing the Adhesive bone conduction hearing device (Adhear) for 2 weeks

  • DeviceContact Mini (CM)

    Patients are wearing the Conventional bone conduction hearing device (Contact Mini) for 2 weeks

06

What researchers measure

Primary outcomes

  1. Wearing time

    Wearing time per day of the two devices

    Time frame: 1 year

07

Study locations

1 site
  • MUW AKH
    Vienna, 1090, Austria
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 2, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03746548
Lead sponsor
Dominik Riss
Responsible party
Dominik Riss (Assoc. Prof. PD. Dr., Medical University of Vienna) — Sponsor-investigator
First posted
Nov 19, 2018
Start date
Jan 1, 2018
Primary completion
Feb 18, 2019
Completion
Jun 30, 2019
Last update
Jan 2, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion